Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors in the central nervous system, conolidine modulates alternate molecular targets. A Science Improvements review found that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://conolidine-nature-s-morph38134.blogthisbiz.com/46330523/not-known-factual-statements-about-conolidin-to-replace-traditional-painkillers